The purpose of this study is to collect information on the effects of treatment for gestational trophoblastic disease (GTD). We plan to use the findings from this study to better understand GTD survivors' health and quality of life. We would like to know more about the health, quality of life and pregnancies of women treated for GTD. This information will be used to try and improve the treatments for women who have this disease.
Study Type
OBSERVATIONAL
Enrollment
59
A patient questionnaire, which includes validated instruments. Data collection methods are as follows: * In person at the medical appointment * Over the telephone * Mailed with self-addressed return envelope and prepaid postage * E-mailed and returned by e-mail, fax or self-addressed envelope and pre-paid postage
A patient questionnaire, which includes validated instruments. Data collection methods are as follows: * In person at the medical appointment * Over the telephone * Mailed with self-addressed return envelope and prepaid postage * E-mailed and returned by e-mail, fax or self-addressed envelope and pre-paid postage
Memorial Sloan Kettering Cancer Center
New York, New York, United States
The primary outcomes include reproductive concerns (as measured by the Reproductive Concern Scale, RCS) and sexual functioning (as measured by the Female Sexual Function Index, FSFI).
Time frame: conclusion of the study
To describe the prevalence of premature menopause and increased bone loss through the Menopausal Symptom Check List and medical follow-up information.
Time frame: conclusion of the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.